TP53 and invasive breast carcinoma: We performed immunohistochemical examination of Ki67 and p53 expression in 150 samples of surgically resected HR-positive invasive breast cancers and analyzed the relationships between combined Ki67-p53 status and clinicopathological factors, including prognosis.